Editorial comment.
Lowe
Franklin C
FC
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D007211:Indoles; C095285:silodosin